Maximise your Horizon Europe funding prospects at our matchmaking event targeting 2026 Pillar II Cluster 1 calls. Unlock new collaboration opportunities by connecting with world-renowned researchers, industry experts, and business leaders to form powerful consortia at this event, co-hosted by Crowdhelix and IDIBAPS.

Benefit from targeted networking, expert-led sessions, and hands-on workshops that streamline proposal development, enhance knowledge exchange, and give participants a competitive edge. Enjoy exclusive access to facility tours and evening networking, all designed to maximise impact and secure valuable partnerships

Targeted Horizon Europe Calls:

CLUSTER HEALTH

• HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
• HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
• HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
• HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
• HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
• HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
• HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
• HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

MISSION CANCER

• HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
• HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
• HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
• HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care

For more information about the targeted calls, please check the 2026 Draft Work Programme.